Login / Signup

Risk factors for grade 3/4 transaminase elevation in patients with chronic lymphocytic leukemia treated with idelalisib.

Jennifer R BrownAndrew ZelenetzRichard FurmanNicole LamannaAnthony MatoMarco MontilloSusan O'BrienRonald DubowyLin GuVeerendra MunugalavadlaTadeusz RobakPeter Hillmen
Published in: Leukemia (2020)
Keyphrases
  • chronic lymphocytic leukemia